Vertex Pharmaceuticals Incorporated
Methods, compositions and kits for increasing genome editing efficiency

Last updated:

Abstract:

Methods of editing a target genomic region(s), methods of repairing of a DNA break via a HDR pathway, methods of inhibiting or suppressing repair of a DNA break via a NHEJ pathway, and methods of modifying expression of a gene(s) or protein(s) comprise administering to one or more cells that include one or more target genomic regions, a genome editing system and a DNA protein-kinase (DNAPK) inhibitor disclosed herein. Kits and compositions for editing a target gene comprise a genome editing system and a DNAPK inhibitor disclosed herein.

Status:
Grant
Type:

Utility

Filling date:

13 Jul 2017

Issue date:

21 Sep 2021